PUBLISHER: The Business Research Company | PRODUCT CODE: 1691872
PUBLISHER: The Business Research Company | PRODUCT CODE: 1691872
High-resolution anoscopy (HRA) is a medical procedure employed to perform a detailed and magnified examination of the anal canal and lower rectum. It is primarily used to detect and assess conditions such as anal intraepithelial neoplasia (AIN), anal cancer, and other abnormalities in the anal region.
The primary products associated with high-resolution anoscopy procedures include colposcopes, portable colposcopes, hand-held colposcopes, anoscopes, disposable anoscopes, and reusable anoscopes. Colposcopes are medical devices utilized by gynecologists and other healthcare professionals for detailed examinations of the cervix, vagina, and vulva. These instruments can be used on both adult and pediatric patients and are commonly found in various healthcare settings, including hospitals, diagnostic laboratories, and specialty clinics, for the examination and assessment of anal and gynecological conditions.
The high-resolution anoscopy market research report is one of a series of new reports from The Business Research Company that provides high-resolution anoscopy market statistics, including high-resolution anoscopy industry global market size, regional shares, competitors with a high-resolution anoscopy market share, detailed high-resolution anoscopy market segments, market trends and opportunities and any further data you may need to thrive in the high-resolution anoscopy industry. This high-resolution anoscopy market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-resolution anoscopy market size has grown strongly in recent years. It will grow from $15.03 billion in 2024 to $16.12 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased prevalence of anal dysplasia, advancements in endoscopy technology, growing awareness and screening, colorectal cancer screening.
The high-resolution anoscopy market size is expected to see strong growth in the next few years. It will grow to $20.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to global health initiatives, expanded access to specialized care, personalized medicine, telemedicine and remote consultations. Major trends in the forecast period include ai-assisted diagnostics, portable hra devices, digital records and telehealth, home-based hra kits.
The growth of the high-resolution anoscopy market is expected to be significantly propelled by the increasing prevalence of cancer. Cancer represents a diverse group of diseases characterized by the uncontrolled proliferation of abnormal cells. High-resolution anoscopy, utilizing specialized equipment like a colposcope or operating microscope, enables healthcare professionals to obtain precise, high-quality imaging, facilitating detailed assessments of the anal canal. This advanced medical technology plays a crucial role in the identification of cancerous lesions and abnormalities within the anal tract. As evidence, the American Cancer Society's "Cancer Facts and Figures 2023" report reveals an upturn in the number of newly reported anal cancer cases in the United States, reaching 9,760 cases compared to 9,440 cases in 2022. Furthermore, the report indicates an increase in the number of deaths attributed to anal cancer, totaling 1,870, in contrast to the 1,670 recorded in 2022. Hence, the expanding prevalence of cancer is a key driver of the high-resolution anoscopy market's growth.
Anticipated market growth in the high-resolution anoscopy sector is attributed to the increased incidence of sexually transmitted diseases (STDs). Sexually transmitted diseases, also referred to as sexually transmitted infections (STIs), are illnesses transmitted through sexual contact, with causative agents encompassing bacteria, viruses, and parasites. Human papillomavirus (HPV) is responsible for anal dysplasia, necessitating the use of high-resolution anoscopy for diagnostic and therapeutic purposes. The heightened prevalence of STIs contributes to the burgeoning high-resolution anoscopy (HRA) market, serving as a critical tool for early cancer detection and disease management. In fact, data from the World Health Organization, a Switzerland-based specialized agency within the United Nations focusing on global public health, indicates that over 1 million cases of sexually transmitted diseases (STDs) are transmitted globally each day, with a majority of these cases remaining asymptomatic. Thus, the amplified incidence of STDs, which increases the risk of anal cancer, is a primary driver of the high-resolution anoscopy market.
Major companies operating in the high-resolution anoscopy market are increasingly adopting new technologies, such as computer-aided cervical mapping, to enhance their treatment-related services and strengthen their market position. Computer-aided colposcopy combined with cervical mapping is an innovative solution that generates data to assist healthcare professionals in quickly identifying cervical abnormalities, improving diagnostic accuracy. For instance, in 2023, Rudolf Riester GmbH, a Germany-based manufacturer of medical devices for hospital and specialist care, launched the LT-300 SD Digital Colposcope. This advanced device allows healthcare providers to perform clinical examinations of the cervix, vulva, vagina, and lower portion of the womb, helping to detect any abnormalities. The LT-300 SD Digital Colposcope is widely used by hospitals, clinics, medical schools, telemedicine providers, assault advocacy programs, and prosecutor's offices across the globe, showcasing its growing role in healthcare diagnostics. This technological advancement demonstrates how companies in the high-resolution anoscopy market are incorporating cutting-edge tools to meet the rising demand for precise, efficient diagnostic solutions.
In December 2022, Olympus, a Japanese company specializing in optical and digital precision technology, completed the acquisition of Odin Vision for an estimated value of $80 million. This strategic acquisition empowers Olympus to integrate Odin's AI solutions into their endoscopy products, providing advanced AI-driven solutions and data-driven insights that have the potential to revolutionize patient care. Odin Vision, based in the UK, is a cloud-AI (artificial intelligence) endoscopy company that aligns with Olympus' vision for innovation in endoscopy and healthcare.
Major companies operating in the high-resolution anoscopy market are Philips Medical Systems Technologies Ltd., Olympus Corporation, Hoya Corporation, Steris PLC, Allegheny Health Network, Karl Storz SE & Co. KG, CooperSurgical, Ecleris S.R.L, Pentax Medical, Fujifilm Medical Systems, Given Imaging, Carl Zeiss Meditec AG, Bovie Medical Corporation, Hill-Rom Holdings Inc., Optomic, Narang Medical Limited, Medorah Meditek Pvt Ltd., Welch Allyn, Leisegang Feinmechanik Optik GmbH, Medimar S.A., DYSIS Medical, Gynius Plus AB, Lutech Medical, Ottomed Endoscopy, Seiler Garepa Pvt. Ltd.
North America was the largest region in the high-resolution anoscopy market in 2024. The regions covered in high-resolution anoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the high-resolution anoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The high-resolution anoscopy market consists of revenues earned by entities by providing services such as anal dysplasia screening, acetic acid application and pathology analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-resolution anoscopy market also includes sales of beveled anoscopes and slotted or side-opening anoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High-Resolution Anoscopy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on high-resolution anoscopy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for high-resolution anoscopy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The high-resolution anoscopy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.